A series of hydroxyl-, methoxy-, and acetoxy-substituted 3- and 4-arylcoumarins were synthesized. All title compounds were screened for their antioxidant capacity, ability to scavenge the 1,1-diphenyl-1-picrylhydrazyl (DPPH) radical, and ability to chelate iron ions. Furthermore, all derivatives were assessed using molecular properties prediction and drug likeness using Molinspiration. It was found that all studied derivatives were potential candidates for further research, as they complied with Lipinski’s rule of five for drug likeness. 3- or 4-arylcoumarins that possess two hydroxyl groups in ortho position, such as 4h, 5b, h, and 6a, had remarkable half-maximal effective concentration (EC50) for radical scavenging, with better performance than known antioxidants in DPPH and metal-chelating assays. In addition, the cupric-reducing antioxidant capacity and ferric-reducing antioxidant power of the synthesized compounds were investigated for antioxidant activity. Among them, 5g, h and 6a, b showed significantly better Trolox equivalent antioxidant capacity (TEAC) than standard compounds. The results demonstrate that the compounds with dihydroxyl groups at 6- and 7-positions of the benzopyrone ring of the arylcoumarin structure are the most active of the series as antioxidants. On the basis of these findings, these new coumarin derivatives are potential therapeutic candidates for pathogenesis of many diseases characterized by free-radical overproduction.
Research on Chemical Intermediates – Springer Journals
Published: Feb 12, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera